Table of Contents
Chapter 1: Executive Summary
Introduction
Scope and Methodology
Size and Growth of the Market
Table 1-1: Global POC Test Market, 2024-2029 ($ million)
Figure 1-1: Global POC Test Market, 2024-2029 ($ million)
Trends Affecting the Market
Competitive Outlook
Sixteen Key Market Conclusions
Conclusion One – POC Market Transformed by Technological Progress
Conclusion Two – POC Molecular Diagnostics Continue Making Inroads
Conclusion Three – Prevention and Early Detection at the Core of POC Development
Conclusion Four – Wearables Continue to Influence POC Markets
Conclusion Five – Test Costs Will Remain a Global Challenge
Conclusion Six – Rising Demand Will Drive POC Growth in RoW Markets
Conclusion Seven – New Venues: Urgent & Retail Care
Conclusion Eight – COVID-19’s Positive Effect
Conclusion Nine – New Opportunities in Infectious Disease POC Testing
Conclusion Ten – Supply Chain Delays
Conclusion Eleven – Multiplex Testing Expands Rapidly
Conclusion Twelve – AI Making Inroads into POC
Conclusion Thirteen – Stand-Alone ER/Urgent Care Centers Gain Acceptance
Conclusion Fourteen – Digital Diagnostics and POC
Conclusion Fifteen – Microfluidics Gaining Ground in POC
Conclusion Sixteen – New Technologies Driving POC Growth
Chapter 2: Introduction and Overview
Point-of-Care Diagnostics Testing
Industry Regulations
Types of CLIA Certificates
POC Industry Drivers
Patient focused drivers
Medical/Healthcare related drivers
Technology drivers
Economic drivers
Other drivers
POC Industry Challenges
POC Test Types
Blood
Urine
Saliva
Hair
Optical Technologies
Breath
Conditions Evaluated by POC Diagnostic Testing
Cancer
Colorectal Cancer
Prostate Cancer
Cardiovascular Disease
Diabetes
Drug Abuse
Infectious Disease
Herpes
HTLV
Respiratory Syncytial Virus
Hepatitis
Lyme Disease
Babesiosis
Gonorrhea, Syphilis and Chlamydia
Trichomonas Vaginalis
HIV/AIDS
Helicobacter Pylori
Influenza
Coronavirus
Mononucleosis
Streptococcus
Osteoporosis
Pregnancy and Fertility
Chapter 3: POC Blood Glucose Tests
Types of Blood Glucose Testing
Fasting Blood Sugar (FBS)
2-Hour Postprandial Blood Sugar (PPBS)
Random Blood Sugar
Glucose Tolerance Test
Glucose Urine Test
Glycated Hemoglobin (HbA1c)
Products
Blood Glucose Self-Testing
Table 3-1: Selected Glucose Self-Test Meter Innovations
Table 3-2: Selected Apps and Glucose Management IT
Continuous Self-Testing
Glycated Hemoglobin Tests
Table 3-3: Selected POC HbA1c Devices
Professional
Market Size and Growth
Table 3-4: Global POC Glucose (including CGM and HbA1c) Testing Market Analysis, 2024-2029 ($ million)
Figure 3-1: Global POC Glucose (including CGM and HbA1c) Testing Market Analysis, 2024-2029 ($ million)
Table 3-5: Global POC Diabetes Sales, by Test Category, 2024-2029 ($ million) [Glucose, Self-test; Glucose, professional; Glucose, continuous; HbA1c, POC]
Figure 3-2: Global POC Diabetes Sales, by Test Category, 2024-2029 ($ million) [Glucose, Self-test; Glucose, professional; Glucose, continuous; HbA1c, POC]
Figure 3-3: Global POC Diabetes Share, by Test Category, 2024 (%) [Glucose, Self-test; Glucose, professional; Glucose, continuous; HbA1c, POC]
Figure 3-4: Global POC Diabetes Share, by Test Category, 2029 (%) [Glucose, Self-test; Glucose, professional; Glucose, continuous; HbA1c, POC]
Regional Analysis
Figure 3-5: POC Blood Glucose Testing Regional Market Analysis, 2024 (%) [Europe, Japan, United States, Rest of World]
POC Glucose Self-Testing
Table 3-6: Global POC Glucose Self-Testing Market, 2024-2029 ($ million)
Figure 3-6: Global POC Glucose Self-Testing Market, 2024-2029 ($ million)
POC Continuous Glucose Self-Testing
Table 3-7: Global POC Continuous Glucose Self-Testing Market, 2024-2029 ($ million)
Figure 3-7: Global POC Continuous Glucose Self-Testing Market, 2024-2029 ($ million)
POC Glucose Professional Testing
Table 3-8: Global POC Glucose Professional Testing Market (excludes HbA1c testing), 2024-2029 ($ million)
Figure 3-8: Global POC Glucose Professional Testing Market (excludes HbA1c testing), 2024-2029 ($ million)
POC HbA1c Testing
Table 3-9: Global POC Glucose HbA1c Professional Testing Market, 2024-2029 ($ million)
Figure 3-9: Global POC Glucose HbA1c Professional Testing Market, 2024-2029 ($ million)
Competitive Analysis
Table 3-10: Global POC Blood Glucose Testing Market (BGM, CGM, HbA1c) Revenues and Market Share of Leading Suppliers, 2024 ($ million) [Abbott, Ascensia, Dexcom, LifeScan, Medtronic, Roche, Others]
Figure 3-10: Global POC Blood Glucose Testing Market (BGM, CGM, HbA1c) Revenues of Leading Suppliers, 2024 ($ million) [Abbott, Ascensia, Dexcom, LifeScan, Medtronic, Roche, Others]
Figure 3-11: Global POC Glucose Test Manufacturer Shares, by Leading Suppliers, 2024 (%) [Abbott, Ascensia, Dexcom, LifeScan, Medtronic, Roche, Others]
Chapter 4: POC Blood and Electrolytes Testing Market
Types of Blood and Electrolytes Tests
Hemoglobin/Hematocrit
WBC and Other
Blood Gases
Electrolytes
Products
Table 4-1: Selected POC Hemoglobin and Hematocrit Systems, 2024
Table 4-2: Selected POC Hematology Analyzer Systems, 2024
Market Size and Growth
Table 4-3: Global POC Blood and Electrolytes Testing (Blood Gases/Electrolytes, Hemoglobin/Hematocrit, WBC) Market Analysis, 2024-2029 ($ million)
Figure 4-1: Global POC Blood and Electrolytes Testing (Blood Gases/Electrolytes, Hemoglobin/Hematocrit, WBC) Market Analysis, 2024-2029 ($ million)
Table 4-4: Global POC Blood & Electrolytes Revenues, by Test Category, 2024-2029 ($ million) [Blood Gases & Electrolytes (inc. critical care), Hematocrit/ Hemoglobin, WBC other routine]
Figure 4-2: Global POC Blood & Electrolytes Revenues, by Test Category, 2024-2029 ($ million) [Blood Gases & Electrolytes (inc. critical care), Hematocrit/ Hemoglobin, WBC other routine]
Figure 4-3: Global POC Blood & Electrolytes Market Share, by Test Category, 2024 (%) [Blood Gases & Electrolytes (inc. critical care), Hematocrit/ Hemoglobin, WBC other routine]
Figure 4-4: Global POC Blood & Electrolytes Market Share, by Test Category, 2029 (%) [Blood Gases & Electrolytes (inc. critical care), Hematocrit/ Hemoglobin, WBC other routine]
Regional Analysis
Figure 4-5: POC Blood and Electrolytes Testing Regional Market Share Analysis, 2024 (%) [Europe, Japan, United States, Rest of World]
POC Blood and Electrolyte Self-Testing
Table 4-5: Global POC Blood and Electrolyte Self Testing Market Analysis, 2024-2029 ($ million)
POC Blood and Electrolyte Professional Testing
Table 4-6: Global POC Blood and Electrolyte Professional Testing Market Analysis, 2024-2029 ($ million)
Competitive Analysis
Table 4-7: Global POC Blood and Electrolyte Testing Market, Revenues and Market Share of Leading Suppliers, 2024 ($ million) [Abbott, Beckman Coulter, Radiometer, Siemens Healthineers, Sysmex, Others]
Figure 4-6: Global POC Blood and Electrolyte Testing Market, Revenues of Leading Suppliers, 2024 ($ million) [Abbott, Beckman Coulter, Radiometer, Siemens Healthineers, Sysmex, Others]
Figure 4-7: Global POC Blood and Electrolyte Testing Market Manufacturer Share, 2024 (%) [Abbott, Beckman Coulter, Radiometer, Siemens Healthineers, Sysmex, Others]
Chapter 5: POC Rapid Coagulation
Products
Table 5-1: Selected POC Coagulation Test Innovations
Platelet Testing
Table 5-2: Selected Platelet Activity Test Innovations
Market Size and Growth
Table 5-3: Global Rapid Coagulation Testing Market Analysis, 2024-2029 ($ million)
Figure 5-1: Global Rapid Coagulation Testing Market Analysis, 2024-2029 ($ million)
Regional Analysis
Figure 5-2: POC Rapid Coagulation Testing Regional Market Share Analysis, 2024 (%) [Europe, Japan, United States, Rest of World]
POC Rapid Coagulation Self-Testing
Table 5-4: POC Rapid Coagulation Self-Testing Market Analysis, 2024-2029 ($ million)
POC Rapid Coagulation Professional Testing
Table 5-5: POC Rapid Coagulation Professional Testing Market Analysis, 2024-2029 ($ million)
Figure 5-3: POC Rapid Coagulation Market Analysis, Self-Testing vs. Professional Testing, 2024-2029 ($ million)
Competitive Analysis
Table 5-6: Global POC Rapid Coagulation Testing Market, Revenues and Market Share of Leading Suppliers, 2024 ($ million)
Figure 5-4: Global POC Rapid Coagulation Testing Market, Revenues of Leading Suppliers, 2024 ($ million)
Figure 5-5: Global POC Rapid Coagulation Testing Market, Market Share of Leading Suppliers, 2024 (%)
Chapter 6: POC Rapid Cardiac Markers
Products
Market Size and Growth
Table 6-1: Total Rapid Cardiac Markers Tests Market Analysis, 2024-2029 ($ million)
Figure 6-1: Total Rapid Cardiac Markers Tests Market Analysis, 2024-2029 ($ million)
Regional Analysis
Figure 6-2: POC Rapid Cardiac Markers Testing Regional Market Share Analysis, 2024 (%) [Europe, Japan, United States, Rest of World]
Competitive Analysis
Table 6-2: Global POC Cardiac Markers Test Market, Revenues and Market Share of Leading Suppliers, 2024 ($ million) [Abbott, QuidelOrtho, Roche, Siemens Healthineers, Others]
Figure 6-3: Global POC Cardiac Markers Test Market, Revenues of Leading Suppliers, 2024 ($ million) [Abbott, QuidelOrtho, Roche, Siemens Healthineers, Others]
Figure 6-4: Global POC Cardiac Markers Test Manufacturers, Market Share of Leading Suppliers, 2024 (%) [Abbott, QuidelOrtho, Roche, Siemens Healthineers, Others]
Chapter 7: POC Substance Abuse
Overview
Products
Urine
Oral
Blood
Hair
Market Size and Growth
Table 7-1: Global POC Drugs of Abuse Testing (critical care, employment, and criminal) Market Analysis, 2024-2029 ($ million)
Figure 7-1: Global POC Drugs of Abuse Testing (critical care, employment, and criminal) Market Analysis, 2024-2029 ($ million)
Regional Analysis
Figure 7-2: POC Substance Abuse Testing Regional Market Share Analysis, 2024 (%) [Europe, Japan, United States, Rest of World]
POC Drugs of Abuse Self-Testing
Table 7-2: Global POC Drugs of Abuse Self Testing Market, 2024-2029 ($ million)
POC Drugs of Abuse Professional Testing
Table 7-3: Global POC Drugs of Abuse Professional Testing Market Analysis, 2024-2029 ($ million)
Figure 7-3: Global POC Drugs of Abuse Market, Self-Testing vs. Professional Testing, 2024-2029 ($ million)
Competitive Analysis
Table 7-4: Global POC Drugs of Abuse Testing Market, Revenues and Market Share of Leading Suppliers, 2024 ($ million) [Abbott, Roche, Siemens Healthineers, Thermo Fisher, Others]
Figure 7-4: Global POC Drugs of Abuse Testing Market, Revenues of Leading Suppliers, 2024 ($ million) [Abbott, Roche, Siemens Healthineers, Thermo Fisher, Others]
Figure 7-5: Global POC Drug of Abuse Testing Manufacturer Market Share, by Leading Suppliers, 2024 (%) [Abbott, Roche, Siemens Healthineers, Thermo Fisher, Others]
Chapter 8: POC Pregnancy and Fertility Testing
Products
Table 8-1: Selected Pregnancy and Fertility CLIA Waivers (Manufacturer and Instrument / Assay), Manufacturer’s Instrument / Device / Assay
Market Size and Growth
Table 8-2: Global POC Pregnancy and Fertility Testing Market Analysis, 2024-2029 ($ million)
Figure 8-1: Global POC Pregnancy and Fertility Testing Market Analysis, 2024-2029 ($ million)
Regional Analysis
Figure 8-2: POC Pregnancy and Fertility Testing Regional Market Share Analysis, 2024 (%) [Europe, Japan, United States, Rest of World]
POC Pregnancy and Fertility Self-Testing
Table 8-3: POC Pregnancy and Fertility Self-Testing Market Analysis, 2024-2029 ($ million)
POC Pregnancy and Fertility Professional Testing
Table 8-4: POC Pregnancy and Fertility Professional Testing Market Analysis, 2024-2029 ($ million)
Figure 8-3: POC Pregnancy and Fertility Market Analysis, Self-Testing vs. Professional Testing, 2024-2029 ($ million)
Competitive Analysis
Table 8-5: Global POC Pregnancy and Fertility Testing Market, Revenues and Market Share of Leading Suppliers, 2024 ($ million) [bioMérieux, Church & Dwight, Meridian, QuidelOrtho, SPD, Others]
Figure 8-4: Global POC Pregnancy and Fertility Testing Market, Revenues of Leading Suppliers, 2024 ($ million) [bioMérieux, Church & Dwight, Meridian, QuidelOrtho, SPD, Others]
Figure 8-5: Global POC Pregnancy and Fertility Testing Manufacturer Share, by Leading Suppliers, 2024 (%) [bioMérieux, Church & Dwight, Meridian, QuidelOrtho, SPD, Others]
Chapter 9: POC Colon Cancer Screening/Fecal Occult Blood Testing
Products
Table 9-1: Selected POC Colon Cancer Tests
Market Size and Growth
Table 9-2: Global POC Colon Cancer Screening/Fecal Occult Blood Testing Market Analysis, 2024-2029 ($ million)
Figure 9-1: Global POC Colon Cancer Screening/Fecal Occult Blood Testing Market Analysis, 2024-2029 ($ million)
Regional Analysis
Figure 9-2: POC Colon Cancer Screening/Fecal Occult Blood Testing Regional Market Share Analysis, 2024 (%) [Europe, Japan, United States, Rest of World]
POC Colon Cancer Screening/Fecal Occult Blood Self-Testing
Table 9-3: POC Colon Cancer Screening/Fecal Occult Blood Self-Testing Market Analysis, 2024-2029 ($ million)
POC Colon Cancer Screening/Fecal Occult Blood Professional Testing
Table 9-4: POC Colon Cancer Screening/Fecal Occult Blood Professional Testing Market Analysis, 2024-2029 ($ million)
Figure 9-3: POC Colon Cancer Screening/Fecal Occult Blood Market Analysis, Self-Testing vs. Professional Testing, 2024-2029 ($ million)
Competitive Analysis
Table 9-5: Global POC Colon Cancer Screening/Fecal Occult Blood Testing Market, Revenues and Market Share of Leading Suppliers, 2024 ($ million)
Figure 9-4: Global POC Colon Cancer Screening/Fecal Occult Blood Testing Market, Revenues of Leading Suppliers, 2024 ($ million) [Beckman Coulter, Exact Sciences, Others]
Figure 9-5: Global POC Colon Cancer Screening/Fecal Occult Blood Testing Manufacturers Share, by Leading Suppliers, 2024 (%) [Beckman Coulter, Exact Sciences, Others]
Chapter 10: POC Infectious Disease Testing
Products
HIV and Hepatitis
Respiratory
STD/STI
Tropical Diseases
Lyme Disease
TB
Zika
Anthrax
Other Bacteria and Viruses
Hospital-Acquired Infections and Sepsis
Sepsis
- Diff
Table 10-1: Selected Innovations in POC Infectious Disease Diagnostics
COVID-19
Antigen
Table 10-2: Selected Antigen POC and Home Immunoassay Tests for SARS-CoV-2
Molecular
Table 10-3: Selected Molecular POC Home Tests for SARS-CoV-2
Market Size and Growth
Table 10-4: Global POC Infectious Disease (including COVID-19) Testing Market Analysis, 2024-2029 ($ million)
Figure 10-1: Global POC Infectious Disease (including COVID-19) Testing Market Analysis, 2024-2029 ($ million)
Regional Analysis
Figure 10-2: POC Infectious Disease (including COVID-19) Testing Regional Market Share Analysis, 2024 (%) [Europe, Japan, United States, Rest of World]
POC Infectious Disease Self-Testing
Table 10-5: POC Infectious Disease Self-Testing (including COVID-19) Market Analysis, 2024-2029 ($ million)
POC Infectious Disease Professional Testing
Table 10-6: POC Infectious Disease (including COVID-19) Professional Testing Market Analysis, 2024-2029 ($ million)
Figure 10-3: POC Infectious Disease Testing (including COVID-19) Market Analysis, Self-Testing vs. Professional Testing, 2024-2029 ($ million)
POC Infectious Disease Testing by Disease Type
Table 10-7: Global POC Infectious Disease Revenues and Percent of Infectious Disease Market, by Disease Type, 2024 ($ million) [C. Diff, COVID-19, E. coli, H. pylori, Hepatitis, HIV, Home Test/OTC, Influenza, Malaria, STD, Others]
Figure 10-4: Global POC Infectious Disease Revenues, by Disease Type, 2024 ($ million) [C. Diff, COVID-19, E. coli, H. pylori, Hepatitis, HIV, Home Test/OTC, Influenza, Malaria, STD, Others]
Figure 10-5: Global POC Infectious Disease, Percent of Infectious Disease Market by Disease Type, 2024 (%) [C. Diff, COVID-19, E. coli, H. pylori, Hepatitis, HIV, Home Test/OTC, Influenza, Malaria, STD, Others]
Competitive Analysis
Table 10-8: Global POC Infectious Disease (including COVID-19) Testing Market, Revenues and Market Share of Leading Suppliers, 2024 ($ million) [Abbott, Becton Dickinson, OraSure, QuidelOrtho, Roche, Siemens Healthineers, Others]
Figure 10-6: Global POC Infectious Disease (including COVID-19) Testing Market, Revenues of Leading Suppliers, 2024 ($ million) [Abbott, Becton Dickinson, OraSure, QuidelOrtho, Roche, Siemens Healthineers, Others]
Figure 10-7: Global POC Infectious Disease (including COVID-19) Testing Manufacturers, Market Share of Leading Suppliers, 2024 (%) [Abbott, Becton Dickinson, OraSure, QuidelOrtho, Roche, Siemens Healthineers, Others]
Chapter 11: POC Lipid Testing
Products
Market Size and Growth
Table 11-1: Global POC Lipid Testing Market Analysis, 2024-2029 ($ million)
Figure 11-1: Global POC Lipid Testing Market Analysis, 2024-2029 ($ million)
Regional Analysis
Figure 11-2: POC Lipid Testing Regional Market Share Analysis, 2024 (%) [Europe, Japan, United States, Rest of World]
POC Lipid Self-Testing
Table 11-2: POC Lipid Self-Testing Market Analysis, 2024-2029 ($ million)
POC Lipid Professional Testing
Table 11-3: POC Lipid Professional Testing Market Analysis, 2024-2029 ($ million)
Figure 11-3: POC Lipid Market Analysis, Self-Testing vs. Professional Testing, 2024-2029 ($ million)
Competitive Analysis
Table 11-4: Global POC Lipid Testing Market, Revenues and Market Share of Leading Suppliers, 2024 ($ million) [Abaxis, Abbott, Roche, Others]
Figure 11-4: Global POC Lipid Testing Market, Revenues of Leading Suppliers, 2024 ($ million) [Abaxis, Abbott, Roche, Others]
Figure 11-5: Global POC Lipid Testing Manufacturers Share, 2024 (%) [Abaxis, Abbott, Roche, Others]
Chapter 12: POC Cancer Tumor Marker Testing
Products
Table 12-1: Selected Companies Developing and/or Marketing POC Tests for Oncology Indications
Market Size and Growth
Table 12-2: Global POC Cancer Testing Market Analysis, 2024-2029 ($ million)
Figure 12-1: Global POC Cancer Testing Market Analysis, 2024-2029 ($ million)
Regional Analysis
Figure 12-2: POC Cancer Tumor Marker Testing Regional Market Share Analysis, 2024 (%) [Europe, Japan, United States, Rest of World]
Competitive Analysis
Table 12-3: Global POC Cancer Testing Market, Revenues and Market Share of Leading Suppliers, 2024 ($ million) [Beckman Coulter, bioMérieux, QuidelOrtho, Others]
Figure 12-3: Global POC Cancer Testing Market, Revenues of Leading Suppliers, 2024 ($ million) [Beckman Coulter, bioMérieux, QuidelOrtho, Others]
Figure 12-4: Global POC Cancer Testing Manufacturers Share, by Leading Suppliers, 2024 (%) [Beckman Coulter, bioMérieux, QuidelOrtho, Others]
Chapter 13: POC Urine Testing
Products
Market Size and Growth
Table 13-1: Global POC Urine Testing Market Analysis, 2024-2029 ($ million)
Figure 13-1: Global POC Urine Testing Market Analysis, 2024-2029 ($ million)
Regional Analysis
Figure 13-2: POC Urine Testing Regional Market Share Analysis, 2024 (%) [Europe, Japan, United States, Rest of World]
POC Urine Self-Testing
Table 13-2: POC Urine Self-Testing Market Analysis, 2024-2029 ($ million)
POC Urine Test Professional Testing
Table 13-3: POC Urine Professional Testing Market Analysis, 2024-2029 ($ million)
Figure 13-3: POC Urine Market Analysis, Self-Testing vs. Professional Testing, 2024-2029 ($ million)
Competitive Analysis
Table 13-4: Global POC Urine Testing Market, Revenues and Market Share of Leading Suppliers, 2024 ($ million) [Eiken Chemical, Roche, Siemens Healthineers, Sysmex, Others]
Figure 13-4: Global POC Urine Testing Market, Revenues of Leading Suppliers, 2024 ($ million) [Eiken Chemical, Roche, Siemens Healthineers, Sysmex, Others]
Figure 13-5: Global POC Urine Strip Testing Manufacturers Share, by Leading Suppliers, 2024 (%) [Eiken Chemical, Roche, Siemens Healthineers, Sysmex, Others]
Chapter 14: Miscellaneous POC Testing
Microbiology
TSH
Allergy
Autoimmune
Others
Market Size and Growth
Table 14-1: Global Miscellaneous POC Testing Market Analysis, 2024-2029 ($ million)
Figure 14-1: Global Miscellaneous POC Testing Market Analysis, 2024-2029 ($ million)
Table 14-2: Global POC Miscellaneous Sales, by Test Category, 2024-2029 ($ million) [Allergy, Autoimmune, Microbiology, TSH, Others]
Figure 14-2: Global POC Miscellaneous Sales, by Test Category, 2024-2029 ($ million) [Allergy, Autoimmune, Microbiology, TSH, Others]
Figure 14-3: Global POC Miscellaneous Market Share, by Test Category, 2024 (%) [Allergy, Autoimmune, Microbiology, TSH, Others]
Figure 14-4: Global POC Miscellaneous Market Share, by Test Category, 2029 (%) [Allergy, Autoimmune, Microbiology, TSH, Others]
POC Miscellaneous Test Sales by Setting
Table 14-3: POC Miscellaneous Test Sales, by Setting, 2024-2029 ($ million) [Self-Testing vs. Professional Testing]
Figure 14-5: POC Miscellaneous Test Sales, by Setting, 2024-2029 ($ million) [Self-Testing vs. Professional Testing]
Regional Analysis
Figure 14-6: POC Miscellaneous Testing Regional Market Share Analysis, 2024 (%) [Europe, Japan, United States, Rest of World]
Chapter 15: Issues and Trends
Overview
Wearables
Table 15-1: Selected Wearable Devices
Mobile Healthcare Technologies
Telehealth
Telehealth eMed to Implement Home Test-to-Treat Program
Patient-centered Healthcare
Breath Test Advances
Table 15-2: Selected Disease Markers in Exhaled Breath
Regulatory Hurdles
Reimbursement Challenges
PAMA
Competition
POC and Molecular Diagnostics
Table 15-3: Selected Market Available Molecular POC Diagnostic Platforms
POC Biosensors and Microfluidics
Table 15-4: Selected FDA-Approved Microfluidic-based POC Tests 2024
Table 15-5: Selected Biochip and Biosensor Players, 2024
China as a POC Market
Emerging POC Technologies
POC Connectivity
COVID-19 Impact
Multiplexed POC Testing
Figure 15-1: Multiplexed POC Testing Schematic
The Emergence of Non-invasive Technologies
Saliva and Swab
Optical Techniques
Near-infrared Scanning
Volatolomics
POC and Antibiotic Resistance Concern
Artificial Intelligence in POC
POC Future in Infectious Disease Diagnostics
Supply Chain Delays
Stand-Alone Emergency Department /Urgent Care Centers Combine with POC Team in New Mexico
Digital Diagnostics
Microfluidics and POC
POC Testing in Genomics and Personalized Medicine
Lab-Developed Tests
CRISPR-Cas Technology and POC
Staffing Shortages
Chapter 16: Total Global POC Testing Market and Competitor Analysis
Market Overview
Table 16-1: Global POC Test Market, 2024-2029 ($ million)
Figure 16-1: Global POC Test Market, 2024-2029 ($ million)
Market Analysis by Product Categories
Table 16-2: Global POC Testing Market Analysis, by Product Category, 2024 ($ million) [Professional Testing, Self-Testing]
Figure 16-2: Global POC Testing Market Analysis, by Product Category, 2024 ($ million) [Professional Testing, Self-Testing]
Figure 16-3: Global POC Testing Market Share Analysis, by Product Category, 2024 (%) [Professional Testing, Self-Testing]
Market Analysis by Subcategory
POC Self-Testing
Table 16-3: Global POC Self-Testing Market Analysis, by Product Category, 2024 ($ million) [Blood & Electrolytes, Coagulation, Drugs of Abuse, Fecal Occult Blood, Glucose (includes CGM), Infectious Disease, Lipid, Pregnancy & Fertility, Urine, Miscellaneous]
Figure 16-4: Global POC Self-Testing Market Analysis, by Product Category, 2024 ($ million) [Blood & Electrolytes, Coagulation, Drugs of Abuse, Fecal Occult Blood, Glucose (includes CGM), Infectious Disease, Lipid, Pregnancy & Fertility, Urine, Miscellaneous]
Figure 16-5: Global POC Self-Testing Market Share Analysis, by Product Category, 2024 (%) [Blood & Electrolytes, Coagulation, Drugs of Abuse, Fecal Occult Blood, Glucose (includes CGM), Infectious Disease, Lipid, Pregnancy & Fertility, Urine, Miscellaneous]
POC Professional Testing
Table 16-4: Global POC Professional Testing Market Analysis, by Product Subcategory, 2024 ($ million) [Blood & Electrolytes, Cancer Tumor Markers, Cardiac Markers, DOA, Fecal Occult Blood, Glucose includes HbA1c, Infectious Disease, Lipid, Pregnancy & Fertility, Product Type, Rapid Coagulation, Urine, Miscellaneous]
Figure 16-6: Global POC Professional Testing Market Analysis, by Product Subcategory, 2024 ($ million) [Blood & Electrolytes, Cancer Tumor Markers, Cardiac Markers, DOA, Fecal Occult Blood, Glucose includes HbA1c, Infectious Disease, Lipid, Pregnancy & Fertility, Product Type, Rapid Coagulation, Urine, Miscellaneous]
Figure 16-7: Global POC Professional Testing Market Analysis, by Product Subcategory, 2024 (%) [Blood & Electrolytes, Cancer Tumor Markers, Cardiac Markers, DOA, Fecal Occult Blood, Glucose includes HbA1c, Infectious Disease, Lipid, Pregnancy & Fertility, Product Type, Rapid Coagulation, Urine, Miscellaneous]
Market Analysis by Country
Table 16-5: Global POC Testing Analysis, by Region/Country, 2024 ($ million) [Europe, Japan, United States, Rest of World]
Figure 16-8: Global POC Testing Analysis, by Region/Country, 2024 ($ million) [Europe, Japan, United States, Rest of World]
Figure 16-9: Global POC Testing Market Analysis, Share by Region/Country, 2024 (%) [Europe, Japan, United States, Rest of World]
United States
Table 16-6: United States POC Testing Market Analysis, 2024-2029 ($ million)
Europe
Table 16-7: Europe POC Testing Market Analysis, 2024-2029 ($ million)
Germany
France
UK
Switzerland and Sweden
Russia and Other Europe
Figure 16-10: Europe POC Testing Participation, Share of European Market by Country, 2024 (%) [France, Germany, Italy, Spain, Switzerland/Norway, United Kingdom, Others]
Japan
Table 16-8: Japan POC Testing Market Analysis, 2024-2029 ($ million)
Rest of World
Latin America
China
India
South Korea
Other Rest of World Countries
Table 16-9: Global POC Testing Market Analysis, by Rest of World Region/Country, 2024 ($ million) [Australia, Canada, China, India, Latin America, the Middle East, South Korea and other Asian countries, Other]
Figure 16-11: Global POC Testing Market Analysis, Share of Rest of World by Region/Country, 2024 (%) [Australia, China, India, Latin America, South Korea, Other]
Competitive Analysis
Table 16-10: Global Top 10 POC Testing Market Revenues and Market Share of Leading Suppliers, 2024 ($ million) [Abbott, Ascensia Diabetes Care, Danaher, Dexcom, Exact Sciences, LifeScan, Medtronic, QuidelOrtho, Roche, Siemens Healthineers, Others]
Figure 16-12: Global Top 10 POC Testing Market Revenues of Leading Suppliers, 2024 ($ million) [Abbott, Ascensia Diabetes Care, Danaher, Dexcom, Exact Sciences, LifeScan, Medtronic, QuidelOrtho, Roche, Siemens Healthineers, Others]
Figure 16-13: Global POC Testing Market Share by Leading Suppliers, 2024 (%) [Abbott, Ascensia Diabetes Care, Danaher, Dexcom, Exact Sciences, LifeScan, Medtronic, QuidelOrtho, Roche, Siemens Healthineers, Others]
Chapter 17: Corporate Profiles
Overview
1 Step Detect Associates, LLC
Table 17-1: 1-Step Detect Associates Corporate Summary
Company Overview
Products
Abbott Laboratories
Table 17-2: Abbott Corporate Summary
Company Overview
Products
Performance Review
Table 17-3: Abbott Revenues, 2020-2024 ($ million)
Abingdon Health Ltd.
Table 17-4: Abingdon Health Corporate Summary
Company Overview
Products
Access Bio, Inc.
Table 17-5: Access Bio Corporate Summary
Company Overview
Products
AccuBioTech Co, Ltd.
Table 17-6: AccuBioTech Corporate Summary
Company Overview
Products
ACON Laboratories, Inc
Table 17-7: ACON Laboratories Corporate Summary
Company Overview
Products
Aerscher Diagnostics, LLC
Table 17-8: Aerscher Diagnostics Corporate Summary
Company Overview
Products
Alfa Scientific Designs, Inc
Table 17-9: Alfa Scientific Corporate Summary
Company Overview
Products
ARKRAY, Inc.
Table 17-10: ARKRAY Corporate Summary
Company Overview
Products
Artron Laboratories, Inc
Table 17-11: Artron Laboratories Corporate Summary
Company Overview
Products
Ascensia Diabetes Care Holdings AG
Table 17-12: Ascensia Diabetes Care Corporate Summary
Company Overview
Products
Autobio Diagnostics Co., Ltd
Table 17-13: Autobio Diagnostics Corporate Summary
Company Overview
Products
Beckman Coulter, Inc
Table 17-14: Beckman Coulter Corporate Summary
Company Overview
Products
Becton Dickinson (BD)
Table 17-15: BD Corporate Summary
Company Overview
Products
Company Financials
Table 17-16: BD Corporation Revenue, 2023-2024 ($ million)
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
Table 17-17: Beijing Wantai Biological Pharmacy Enterprise Corporate Summary
Company Overview
Products
Bhat Bio-Tech India Private Ltd. (BBI)
Table 17-18: Bhat Bio-Tech India Private Corporate Summary
Company Overview
Products
binx health
Table 17-19: binx health Corporate Summary
Company Overview
Products
bioLytical Laboratories
Table 17-20: bioLytical Laboratories Corporate Summary
Company Overview
Products
BioMedomics, Inc
Table 17-21: BioMedomics Corporate Summary
Company Overview
Products
Biomeme, Inc
Table 17-22: Biomeme Corporate Summary
Company Overview
Products
Biomerica, Inc.
Table 17-23: Biomerica Corporate Summary
Company Overview
Products
Company Financials
Table 17-24: Biomerica Corporation Revenue, 2020-2024 ($ million)
bioMérieux SA
Table 17-25: bioMérieux SA Corporate Summary
Company Overview
Products
Company Financials
Table 17-26: bioMérieux Revenues, 2023-2024 (€ million)
Bio-Rad Laboratories Inc.
Table 17-27: Bio-Rad Labs Corporate Summary
Company Overview
Products
Company Financials
Table 17-28: Bio-Rad Corporation Revenue, 2023-2024 ($ million)
Biosynex SA
Table 17-29: Biosynex SA Corporate Summary
Company Overview
Products
Biotron Diagnostics, Inc.
Table 17-30: Biotron Diagnostics Corporate Summary
Company Overview
Products
Boditech Med Inc
Table 17-31: Boditech Med Corporate Summary
Company Overview
Products
Performance Review
Table 17-32: Boditech Med Revenues, 2023-2024 (KRW billion)
Boson Biotech Co. Ltd
Table 17-33: Boson Biotech Corporate Summary
Company Overview
Products
BTNX Inc.
Table 17-34: BTNX Corporate Summary
Company Overview
Products
Cepheid, Inc
Table 17-35: Cephid Corporate Summary
Company Overview
Products
Chembio Diagnostics Systems, Inc. (Biosynex)
Table 17-36: Chembio Diagnostic Corporate Summary
Company Overview
Products
Church & Dwight Co. Inc
Table 17-37: Church & Dwight Corporate Summary
Company Overview
Products
Performance Review
Table 17-38: Church and Dwight Revenues, 2023-2024 ($ million)
Clarity Diagnostics, LLC
Table 17-39: Clarity Diagnostics Corporate Summary
Company Overview
Products
Confirm Biosciences
Table 17-40: Confirm Biosciences Corporate Summary
Company Overview
Products
CTK Biotech, Inc.
Table 17-41: CTK Biotech Corporate Summary
Company Overview
Products
Cue Health
Table 17-42: Cue Health Corporate Summary
Company Overview
Products
Danaher Corporation
Table 17-43: Danaher Corporation Summary
Company Overview
Products
Dexcom, Inc
Table 17-44: Dexcom Corporate Summary
Company Overview
Products
Performance Review
Table 17-45: Dexcom Revenues, 2023-2024 ($ million)
DIALAB GmbH
Table 17-46: DIALAB Corporate Summary
Company Overview
Products
DiaSys Diagnostic Systems GmbH (Mindray)
Table 17-47: DiaSys Diagnostic Systems Corporate Summary
Company Overview
Products
Diazyme Laboratories, Inc.
Table 17-48: Diazyme Laboratories Corporate Summary
Company Overview
Products
DNA Electronics Ltd. (DNAe)
Table 17-49: DNA Electronics Corporate Summary
Company Overview
Products
Dr. Fooke-Achterrath Laboratorien GmbH
Table 17-50: Dr. Fooke-Achterrath Laboratorien Corporate Summary
Company Overview
Products
DxGen Corp.
Table 17-51: DxGen Corporate Summary
Company Overview
Products
Eiken Chemical Co Ltd.
Table 17-52: Eiken Chemical Corporate Summary
Company Overview
Products
Performance Review
Table 17-53: Eiken Chemical Revenues, 2023-2024 (million yen)
EKF Diagnostics Holdings plc
Table 17-54: EKF Diagnostics Corporate Summary
Company Overview
Products
ELITechGroup S.A.S.
Table 17-55: ELITechGroup Corporate Summary
Company Overview
Products
Eurobio Scientific
Table 17-56: Eurobio Scientific Corporate Summary
Company Overview
Products
Everlywell
Table 17-57: Everlywell Corporate Summary
Company Overview
Products
Exact Sciences
Table 17-58: Exact Sciences Corporate Summary
Company Overview
Products
Performance Review
Table 17-59: Exact Sciences Revenues, 2023-2024 ($ million)
EY Laboratories
Table 17-60: EY Laboratories Corporate Summary
Company Overview
Products
GenBio
Table 17-61: GenBio Corporate Summary
Company Overview
Products
genedrive plc
Table 17-62: genedrive Corporate Summary
Company Overview
Products
Performance Review
Table 17-63: genedrive Revenue, 2023-2024 (£ million)
GeTein Biotech Inc.
Table 17-64: GeTein Corporate Summary
Company Overview
Products
Helena Laboratories
Table 17-65: Helena Laboratories Corporate Summary
Company Overview
Products
Hemosure, Inc. (W.H.P.M)
Table 17-66: Hemosure Corporate Summary
Company Overview
Products
HORIBA, Ltd.
Table 17-67: HORIBA Corporate Summary
Company Overview
Products
Immune IQ
Table 17-68: Immune IQ Corporate Summary
Company Overview
Products
Immunostics, Inc
Table 17-69: Immunostics Corporate Summary
Company Overview
Products
JAL Innovation PTE LTD
Table 17-70: JAL Innovation Corporate Summary
Company Overview
Products
Jant Pharmacal Corporation
Table 17-71: Jant Pharmacal Corporate Summary
Company Overview
Products
- Mitra & Co Pvt. Ltd
Table 17-72: J Mitra Corporate Summary
Company Overview
Products
Kypha
Table 17-73: Kypha Corporate Summary
Company Overview
Products
LamdaGen Corporation
Table 17-74: LamdaGen Corporate Summary
Company Overview
Products
LifeScan, Inc
Table 17-75: LifeScan Corporate Summary
Company Overview
Products
LifeSign, LLC
Table 17-76: LifeSign Corporate Summary
Company Overview
Products
LightDeck Diagnostics
Table 17-77: LightDeck Diagnostics Corporate Summary
Company Overview
Products
LumiraDx UK Limited
Table 17-78: LumiraDx Corporate Summary
Company Overview
Products
Macherey-Nagel GmbH & Co. KG
Table 17-79: Macherey-Nagel Corporate Summary
Company Overview
Products
Medix Biochemica
Table 17-80: Medix Biochemica Corporate Summary
Company Overview
Products
MedMira, Inc
Table 17-81: MedMira Corporate Summary
Company Overview
Products
Performance Review
Table 17-82: MedMira Revenues, 2023-2024 ($ thousands)
Medtronic, Inc.
Table 17-83: Medtronic Corporate Summary
Company Overview
Products
Performance Review
Table 17-84: Medtronic Revenues, 2023-2024 ($ billion)
- Menarini Diagnostics srl.
Table 17-85: Menarini Diagnostics Corporate Summary
Company Overview
Products
Meridian Bioscience, Inc
Table 17-86: Meridian Bioscience Corporate Summary
Company Overview
Products
MiCo BioMed
Table 17-87: MiCo BioMed Summary
Company Overview
Products
Nano-Ditech Corporation
Table 17-88: Nano-Ditech Corporate Summary
Company Overview
Products
Nexus Dx Inc
Table 17-89: Nexus Dx Corporate Summary
Company Overview
Products
NG Biotech
Table 17-90: NG Biotech Corporate Summary
Company Overview
Products
Noble Medical, Inc
Table 17-91: Noble Medical Corporate Summary
Company Overview
Products
Nova Biomedical Corp.
Table 17-92: Nova Biomedical Corporate Summary
Company Overview
Products
Oasis Diagnostics Corporation
Table 17-93: Oasis Diagnostics Corporate Summary
Company Overview
Products
Operon S.A.
Table 17-94: Operon Corporate Summary
Company Overview
Products
OPKO Health, Inc
Table 17-95: OPKO Health Corporate Summary
Company Overview
Products
Performance Review
Table 17-96: OPKO Health Revenues, 2023-2024 ($ million)
OraSure Technologies, Inc.
Table 17-97: OraSure Technologies Corporate Summary
Company Overview
Products
Performance Review
Table 17-98: OraSure Revenues, 2023-2024 ($ million)
PixCell Medical Technologies
Table 17-99: PixCell Corporate Summary
Company Overview
Products
Polymedco, Inc
Table 17-100: Polymedco Corporate Summary
Company Overview
Products
PTS Diagnostics
Table 17-101: PTS Corporate Summary
Company Overview
Products
Preventis GmbH
Table 17-102: Preventis Corporate Summary
Company Overview
Products
Princeton Biomeditech Corporation
Table 17-103: Princeton Biomeditech Corporate Summary
Company Overview
Products
QuantuMDx Group Limited
Table 17-104: QuantuMDx Group Corporate Summary
Company Overview
Products
QuidelOrtho Corporation
Table 17-105: QuidelOrtho Corporate Summary
Company Overview
Products
Performance Review
Table 17-106: QuidelOrtho Revenues, 2023-2024 ($ million)
Precision Biosensor
Table 17-107: Precision Biosensor Corporate Summary
Company Overview
Products
Radiometer Medical A/S
Table 17-108: Radiometer Medical Corporate Summary
Company Overview
Products
Randox Laboratories Limited
Table 17-109: Randox Labs Corporate Summary
Company Overview
Products
Response Biomedical Corp
Table 17-110: Response Biomedical Corporate Summary
Company Overview
Products
Reszon Diagnostics International Sdn. Bhd.
Table 17-111: Reszon Diagnostics Corporate Summary
Company Overview
Products
Roche Diagnostic Corporation
Table 17-112: Roche Diagnostic Corporate Summary
Company Overview
Products
Table 17-113: Roche POC Marketed Products
Performance Review
Table 17-114: Roche Diagnostics, 2023-2024 (CHF millions)
Savyon Diagnostics
Table 17-115: Savyon Diagnostics Corporate Summary
Company Overview
Products
Sekisui Diagnostics LLC
Table 17-116: Sekisui Diagnostics Corporate Summary
Company Overview
Products
Siemens Healthineers GmbH
Table 17-117: Siemens Healthineers Corporate Summary
Company Overview
Products
Performance Review
Table 17-118: Siemens Healthineers, 2023-2024 (€ millions)
Sysmex Corporation
Table 17-119: Sysmex Corporate Summary
Company Overview
Products
Performance Review
Table 17-120: Sysmex, 2023-2024 (billion yen)
TECHLAB, Inc.
Table 17-121: TECHLAB Corporate Summary
Company Overview
Products
Trinity Biotech PLC
Table 17-122: Trinity Biotech Corporate Summary
Company Overview
Products
Trividia Health
Table 17-123: Trividia Health Corporate Summary
Company Overview
Products
Tulip Diagnostics Ltd (Tulip Group)
Table 17-124: Tulip Diagnostics Corporate Summary
Company Overview
Product
VedaLab
Table 17-125: VedaLab Corporate Summary
Company Overview
Products
Werfen
Table 17-126: Werfen Corporate Summary
Company Overview
Products
